JP7447110B2 - テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物 - Google Patents

テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物 Download PDF

Info

Publication number
JP7447110B2
JP7447110B2 JP2021523927A JP2021523927A JP7447110B2 JP 7447110 B2 JP7447110 B2 JP 7447110B2 JP 2021523927 A JP2021523927 A JP 2021523927A JP 2021523927 A JP2021523927 A JP 2021523927A JP 7447110 B2 JP7447110 B2 JP 7447110B2
Authority
JP
Japan
Prior art keywords
fluoro
pharmaceutically acceptable
compound
acceptable salt
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021523927A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022506524A (ja
JP2022506524A5 (https=
Inventor
グリッロ，マーク
ケイン，ブライアン
オスロブ，ヨハン
ヂョン，ミン
トンプソン，ファビアンヌ
Original Assignee
マイオカーディア，インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マイオカーディア，インク filed Critical マイオカーディア，インク
Publication of JP2022506524A publication Critical patent/JP2022506524A/ja
Publication of JP2022506524A5 publication Critical patent/JP2022506524A5/ja
Priority to JP2024028058A priority Critical patent/JP7703716B2/ja
Application granted granted Critical
Publication of JP7447110B2 publication Critical patent/JP7447110B2/ja
Priority to JP2025106973A priority patent/JP2025138748A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hospice & Palliative Care (AREA)
JP2021523927A 2018-10-29 2019-10-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物 Active JP7447110B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024028058A JP7703716B2 (ja) 2018-10-29 2024-02-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP2025106973A JP2025138748A (ja) 2018-10-29 2025-06-25 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862752278P 2018-10-29 2018-10-29
US62/752,278 2018-10-29
PCT/US2019/058297 WO2020092208A1 (en) 2018-10-29 2019-10-28 Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024028058A Division JP7703716B2 (ja) 2018-10-29 2024-02-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Publications (3)

Publication Number Publication Date
JP2022506524A JP2022506524A (ja) 2022-01-17
JP2022506524A5 JP2022506524A5 (https=) 2022-11-01
JP7447110B2 true JP7447110B2 (ja) 2024-03-11

Family

ID=68841171

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021523927A Active JP7447110B2 (ja) 2018-10-29 2019-10-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP2024028058A Active JP7703716B2 (ja) 2018-10-29 2024-02-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP2025106973A Pending JP2025138748A (ja) 2018-10-29 2025-06-25 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024028058A Active JP7703716B2 (ja) 2018-10-29 2024-02-28 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP2025106973A Pending JP2025138748A (ja) 2018-10-29 2025-06-25 テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Country Status (29)

Country Link
US (5) US11034693B2 (https=)
EP (3) EP4736855A2 (https=)
JP (3) JP7447110B2 (https=)
KR (2) KR102797129B1 (https=)
CN (3) CN113056465B (https=)
AR (1) AR116880A1 (https=)
AU (2) AU2019373206B2 (https=)
BR (1) BR112021008077A2 (https=)
CA (1) CA3118293A1 (https=)
CL (1) CL2021001083A1 (https=)
CO (1) CO2021005540A2 (https=)
DK (2) DK3873904T3 (https=)
EA (1) EA202191152A1 (https=)
ES (1) ES2986923T3 (https=)
FI (2) FI3873904T3 (https=)
HR (2) HRP20241065T1 (https=)
HU (1) HUE068265T2 (https=)
IL (2) IL325304A (https=)
LT (2) LT3873904T (https=)
MX (2) MX2021004955A (https=)
PE (1) PE20211780A1 (https=)
PL (1) PL3873904T3 (https=)
PT (1) PT3873904T (https=)
RS (1) RS65963B1 (https=)
SG (1) SG11202104218SA (https=)
SI (2) SI3873904T1 (https=)
SM (1) SMT202400358T1 (https=)
TW (3) TW202521537A (https=)
WO (1) WO2020092208A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024063091A (ja) * 2018-10-29 2024-05-10 マイオカーディア，インク テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3088347A1 (en) 2018-01-17 2019-07-25 Glaxosmithkline Intellectual Property Development Limited Pi4kiii.beta. inhibitors
MX2023002024A (es) 2020-08-28 2023-05-10 Myokardia Inc Métodos de tratamiento con modulador de miosina.
CN114149423B (zh) * 2020-09-08 2023-12-12 江苏恒瑞医药股份有限公司 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
CN114456163B (zh) * 2020-11-09 2023-08-11 江苏恒瑞医药股份有限公司 四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
WO2022105852A1 (zh) 2020-11-20 2022-05-27 江苏恒瑞医药股份有限公司 三嗪二酮类衍生物、其制备方法及其在医药上的应用
CN117083275A (zh) 2021-03-04 2023-11-17 赛特凯恩蒂克公司 心脏肌节抑制剂
CN119053591A (zh) 2022-05-20 2024-11-29 江苏恒瑞医药股份有限公司 一种三嗪二酮类衍生物的晶型及制备方法
IL318417A (en) 2022-07-29 2025-03-01 Myokardia Inc Crystalline forms of (6s,7s)-6-fluoro-7-(2-fluoro-5-methylphenyl)-3-(tetrahydro-2h-pyran-4-yl)-5,6,7,8-tetrahydropyrido[2 ,3-d]pyrimidine-2,4(lh,3h)-dione

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160176868A1 (en) 2014-12-18 2016-06-23 MyoKardia, Inc. Bicyclic-pyrimidinedione compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU725689B2 (en) 1995-06-07 2000-10-19 G.D. Searle & Co. Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for treatment of congestive heart failure
GB9715892D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
SMT202000071T1 (it) * 2013-06-21 2020-03-13 Myokardia Inc Composti di pirimidinadione contro le condizioni cardiache
EA202191152A1 (ru) 2018-10-29 2022-01-19 Миокардиа, Инк. Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160176868A1 (en) 2014-12-18 2016-06-23 MyoKardia, Inc. Bicyclic-pyrimidinedione compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024063091A (ja) * 2018-10-29 2024-05-10 マイオカーディア，インク テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP7703716B2 (ja) 2018-10-29 2025-07-15 マイオカーディア，インク テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物

Also Published As

Publication number Publication date
FI4464321T3 (fi) 2026-03-11
TWI876902B (zh) 2025-03-11
IL282740A (en) 2021-06-30
JP2025138748A (ja) 2025-09-25
JP2024063091A (ja) 2024-05-10
EP4736855A2 (en) 2026-05-06
US11034693B2 (en) 2021-06-15
AU2019373206B2 (en) 2024-11-14
PT3873904T (pt) 2024-10-08
PL3873904T3 (pl) 2024-12-23
ES2986923T3 (es) 2024-11-13
AR116880A1 (es) 2021-06-23
WO2020092208A1 (en) 2020-05-07
TWI837202B (zh) 2024-04-01
KR20210086673A (ko) 2021-07-08
JP7703716B2 (ja) 2025-07-15
CN113056465B (zh) 2025-01-28
SI4464321T1 (sl) 2026-03-31
CN119977963A (zh) 2025-05-13
TW202426449A (zh) 2024-07-01
US20250282779A1 (en) 2025-09-11
SMT202400358T1 (it) 2024-11-15
HUE068265T2 (hu) 2024-12-28
US20240025894A1 (en) 2024-01-25
CO2021005540A2 (es) 2021-07-30
KR102797129B1 (ko) 2025-04-18
SI3873904T1 (sl) 2024-10-30
RS65963B1 (sr) 2024-10-31
DK3873904T3 (da) 2024-08-05
HRP20260161T1 (hr) 2026-03-27
EP4464321A2 (en) 2024-11-20
MX2021004955A (es) 2021-07-21
EP3873904B1 (en) 2024-07-10
AU2019373206A1 (en) 2021-06-17
TW202521537A (zh) 2025-06-01
CN113056465A (zh) 2021-06-29
LT4464321T (lt) 2026-03-25
BR112021008077A2 (pt) 2021-08-03
CN119977962A (zh) 2025-05-13
EA202191152A1 (ru) 2022-01-19
EP3873904A1 (en) 2021-09-08
IL325304A (en) 2026-02-01
HRP20241065T1 (hr) 2024-11-08
EP4464321A3 (en) 2025-01-01
DK4464321T3 (da) 2026-02-09
LT3873904T (lt) 2024-11-11
JP2022506524A (ja) 2022-01-17
EP4464321B1 (en) 2026-01-21
MX2024004892A (es) 2024-05-07
SG11202104218SA (en) 2021-05-28
IL282740B1 (en) 2026-01-01
US20220340569A1 (en) 2022-10-27
US12344607B2 (en) 2025-07-01
CA3118293A1 (en) 2020-05-07
TW202030189A (zh) 2020-08-16
AU2025200975A1 (en) 2025-03-06
CL2021001083A1 (es) 2021-09-24
KR20250053228A (ko) 2025-04-21
US20220106314A1 (en) 2022-04-07
PE20211780A1 (es) 2021-09-08
US20200165247A1 (en) 2020-05-28
FI3873904T3 (fi) 2024-08-09

Similar Documents

Publication Publication Date Title
JP7447110B2 (ja) テトラヒドロピラン（ｔｈｐ）－置換二環式－ピリミジンジオン化合物
JP7830321B2 (ja) ミオシンモジュレーターによる治療方法
HK40119292A (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
JP2007538054A (ja) 肥満および関係する病気の予防または治療のためのｎ−スルファモイル−ｎ′−アリールピペラジンを含有する薬剤
HK40061965B (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
HK40061965A (en) Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds
EA053114B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
EA050645B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
WO2009153261A1 (en) HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
EA046692B1 (ru) Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221024

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221024

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20231026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240124

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240213

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240228

R150 Certificate of patent or registration of utility model

Ref document number: 7447110

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150